These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 23279759)

  • 21. Anticoagulation control in Sweden: reports of time in therapeutic range, major bleeding, and thrombo-embolic complications from the national quality registry AuriculA.
    Wieloch M; Själander A; Frykman V; Rosenqvist M; Eriksson N; Svensson PJ
    Eur Heart J; 2011 Sep; 32(18):2282-9. PubMed ID: 21616951
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cardiomyopathy and embolization: risks and benefits of anticoagulation in sinus rhythm.
    Rho R; DeNofrio D; Loh E
    Curr Cardiol Rep; 2000 Mar; 2(2):106-11. PubMed ID: 10980880
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cardiovascular effects of continuous positive airway pressure in patients with heart failure and obstructive sleep apnea.
    Kaneko Y; Floras JS; Usui K; Plante J; Tkacova R; Kubo T; Ando S; Bradley TD
    N Engl J Med; 2003 Mar; 348(13):1233-41. PubMed ID: 12660387
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Safety of new oral anticoagulants with dual antiplatelet therapy in patients with acute coronary syndromes.
    Tsu LV; Dager WE
    Ann Pharmacother; 2013 Apr; 47(4):573-7. PubMed ID: 23548645
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anticoagulation in patients with dilated cardiomyopathy and sinus rhythm: a critical literature review.
    Sirajuddin RA; Miller AB; Geraci SA
    J Card Fail; 2002 Feb; 8(1):48-53. PubMed ID: 11862583
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Improving survival rates of patients with idiopathic dilated cardiomyopathy in Tuscany over 3 decades: impact of evidence-based management.
    Castelli G; Fornaro A; Ciaccheri M; Dolara A; Troiani V; Tomberli B; Olivotto I; Gensini GF
    Circ Heart Fail; 2013 Sep; 6(5):913-21. PubMed ID: 23888044
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recovery of normal ventricular function in patients with dilated cardiomyopathy: predictors of an increasingly prevalent clinical event.
    Binkley PF; Lesinski A; Ferguson JP; Hatton PS; Yamokoski L; Hardikar S; Cooke GE; Leier CV
    Am Heart J; 2008 Jan; 155(1):69-74. PubMed ID: 18082492
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thrombosis and embolism in pediatric cardiomyopathy.
    Chen K; Williams S; Chan AK; Mondal TK
    Blood Coagul Fibrinolysis; 2013 Apr; 24(3):221-30. PubMed ID: 23429248
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Apixaban for stroke prevention in atrial fibrillation: a review of the clinical trial evidence.
    Yates SW
    Hosp Pract (1995); 2011 Oct; 39(4):7-16. PubMed ID: 22056819
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A comparison of anticoagulation, antiplatelet, and placebo treatment for patients with heart failure reduced ejection fraction in sinus rhythm: a systematic review and meta-analysis.
    Sulaica EM; Macaulay TE; Helbing RR; Abo-Aly M; Abdel-Latif A; Wanat MA
    Heart Fail Rev; 2020 Mar; 25(2):207-216. PubMed ID: 31256317
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Beta blocking agents in the treatment of dilated cardiomyopathy: review of the literature and clinical experience with 67 patients].
    Sinagra G; Perkan A; Di Lenarda A; Lardieri G; Pinamonti B; Mestroni L; Miani D; Camerini F
    G Ital Cardiol; 1992 Aug; 22(8):969-89. PubMed ID: 1362167
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Occurrence and characteristics of stroke events in the Atrial Fibrillation Follow-up Investigation of Sinus Rhythm Management (AFFIRM) study.
    Sherman DG; Kim SG; Boop BS; Corley SD; Dimarco JP; Hart RG; Haywood LJ; Hoyte K; Kaufman ES; Kim MH; Nasco E; Waldo AL;
    Arch Intern Med; 2005 May; 165(10):1185-91. PubMed ID: 15911734
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A controlled study of the effects of carvedilol on clinical events, left ventricular function and proinflammatory cytokines levels in patients with dilated cardiomyopathy.
    Tatli E; Kurum T
    Can J Cardiol; 2005 Mar; 21(4):344-8. PubMed ID: 15838561
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel oral anticoagulants in secondary prevention of stroke.
    Diener HC; Easton JD; Hankey GJ; Hart RG
    Best Pract Res Clin Haematol; 2013 Jun; 26(2):131-9. PubMed ID: 23953901
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of dilated cardiomyopathy with carvedilol in children.
    Erdoğan I; Ozer S; Karagöz T; Celiker A; Ozkutlu S; Alehan D
    Turk J Pediatr; 2009; 51(4):354-60. PubMed ID: 19950843
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of benazepril on heart rate turbulence in patients with dilated cardiomyopathy.
    Zhong JH; Chen XP; Zeng CF; Yun ML; Yang XW; Chen YF; Yao Z
    Clin Exp Pharmacol Physiol; 2007 Jul; 34(7):612-6. PubMed ID: 17581217
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Potential net clinical benefit of population-wide implementation of apixaban and dabigatran among European patients with atrial fibrillation. A modelling analysis from the Euro Heart Survey.
    Pisters R; Nieuwlaat R; Lane DA; Crijns HJ; Lip GY
    Thromb Haemost; 2013 Feb; 109(2):328-36. PubMed ID: 23179181
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Heart rate variability in heart failure.
    Musialik-Łydka A; Sredniawa B; Pasyk S
    Kardiol Pol; 2003 Jan; 58(1):10-6. PubMed ID: 14502297
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anticoagulation in dilated cardiomyopathy.
    Koniaris LS; Goldhaber SZ
    J Am Coll Cardiol; 1998 Mar; 31(4):745-8. PubMed ID: 9525541
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anticoagulation in patients with heart failure and normal sinus rhythm.
    Ripley TL; Nutescu E
    Am J Health Syst Pharm; 2009 Jan; 66(2):134-41. PubMed ID: 19139477
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.